Metabolic rewiring induces a viral mimicry-mediated quiescence in glioblastoma
Chesnelong, C.; Desai, K.; Charton, C. S.; Kushida, M.; Yu, C.; Guilhamon, P.; Lee, L.; Agnihotri, S.; Dirks, P. B.
Show abstract
Glioblastoma is a highly aggressive brain tumour driven by therapy-resistant glioblastoma stem cells (GSCs) that switch between dormant and proliferative states through poorly defined programs. In this study, we identify SAT1, encoding the rate-limiting polyamine-catabolic enzyme SSAT1, as enriched in quiescent GSCs, linking metabolic rewiring to dormancy. Pharmacologic induction of SSAT1 with the polyamine analogue N1,N11-Diethylnorspermine (DENSpm) triggers a chemoprotective, reversible growth arrest in patient-derived GSCs, independent of stemness, differentiation or senescence. SAT1-induced dormancy coincides with reduced eIF5A hypusination and global protein translation, and a marked rise in double-stranded RNA that activates type I interferon signalling. Knocking down the mitochondrial antiviral-signalling protein, essential for antiviral innate immunity, partially reverses this growth arrest, establishing viral mimicry as functionally required for dormancy. Single-cell and cohort analyses across GSCs and neural stem cells demonstrate that susceptibility to metabolically induced quiescence is set by an intrinsic inflammatory tone and lysosomal dependency, defining a context-dependent metabolic-immune axis which can be targeted to prevent GBM progression.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Cellular senescence in malignant cells promotes tumor progression in mouse and patient Glioblastoma 95%
- Agonistic CD40 antibody therapy induces tertiary lymphoid structures but impairs the response to immune checkpoint blockade in glioma 94%
- MGMT genomic rearrangements contribute to chemotherapy resistance in gliomas 94%
Similar papers in this journal
Similar papers in this journal
Similar papers in this journal
- Distinct tumor immune microenvironmental (TIME) landscapes drive divergent immunotherapy responses in glioblastoma 95%
- Pyruvate carboxylation identifies Glioblastoma Stem-like Cells opening new metabolic strategy to prevent tumor recurrence 94%
- Immune Contexture of Isocitrate Dehydrogenase stratified Human Gliomas 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.